Use of HDAC inhibitors for the treatment of gastrointestinal cancers

Details for Australian Patent Application No. 2008247603 (hide)

Owner Novartis AG

Inventors Atadja, Peter Wisdom

Agent Davies Collison Cave

Pub. Number AU-A-2008247603

PCT Pub. Number WO2008/137630

Priority 60/915,996 04.05.07 US

Filing date 2 May 2008

Wipo publication date 13 November 2008

International Classifications

A61K 31/4045 (2006.01)

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

22 October 2009 PCT application entered the National Phase

  PCT publication WO2008/137630 Priority application(s): WO2008/137630

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247605-Antimicrobial compositions, products, and methods of use

2008247595-Aminopyrimidines useful as kinase inhibitors